Optiver Holding
TNGX icon

Optiver Holding’s Tango Therapeutics TNGX Stock Holding History

Optiver Holding’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.58K Sell
410
-166
-29% -$2.31K ﹤0.01% 1256
2025
Q4 		$5.1K Sell
576
-38
-6% -$327 ﹤0.01% 1357
2025
Q3 		$5.16K Buy
+614
New +$4.16K ﹤0.01% 1713

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Optiver Holding's TNGX Position: Q1 2026 in Review

Optiver Holding reduced its Tango Therapeutics (TNGX) stake by 29% in Q1 2026, selling an estimated $2.31K and leaving 410 shares worth $8.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Optiver Holding first reported a position in TNGX in Q3 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Optiver Holding held 410 shares of Tango Therapeutics worth $8.58K as of Q1 2026.
  • Optiver Holding sold 166 Tango Therapeutics shares in Q1 2026, an estimated $2.31K.
  • Tango Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1256 holding.
  • Optiver Holding first reported a position in Tango Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.